¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hepatitis carrier state"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® carrier ÇÑ±Û º¸±ÕÀÚ, º¸ÃæÀÚ, º¸ÀÎÀÚ, ³ª¸£°³
¼³¸í   
  1. Áõ»ó¾øÀ̠ü³»¿¡ º´¿ø¹Ì»ý¹°ÀÌ Á¸ÀçÇÏ¿© °¨¿°ÀüÆÄÀÚÀÇ ¿ªÇÒÀ» Çϴ °³Ã¼. ÀÌ·¯ÇÑ °³Ã¼¸¦ º¸±Õ»óÅÂ(carrier state)¶ó ºÎ¸£°í ÀÖ´Ù. 2. ³ª¸£°³. ¼¼Æ÷³»ÀÇ ¹°Áú·Î¼­ ÇѰ³ ¶Ç´Â µÎ°³ÀÇ ÀüÀÚ¸¦ ¹Þ¾Æ È¯¿øµÇ³ª ±× ÈÄ ´Ù½Ã »êÈ­µÉ ¼ö Àִ °Í. 3. º¸ÀÎÀÚ. º¸Åë¿°»öü¼ºÀ̵砼º¿°»öü¼ºÀ̵砰£¿¡ ±× Á¤»óÀÇ ´ë¸³À¯ÀüÀÚ¿Í ´õºÒ¾î ¿­¼ºÀ¯ÀüÀÚ¸¦ º¸À¯Çϴ °³Ã¼. 4. ¹æ»ç¼±Çп¡¼­ ´Ù¸¥ ¹°Áú ÃßÀûÀÚ¿Í °°ÀÌ »ç¿ëµÇ¸ç, È­ÇÐÀû ¹°¸®Àû ÀÛ¿ëÀ¸·Î ±× ÃßÀûÀÚ¸¦ ¿î¹ÝÇϴ ¹°Áú. 5. ¼¼Æ÷³»¸·À» ÅëÇÑ ¿î¼ÛÀÇ °æ¿ì¿Í °°ÀÌ ¾î¶² ¹°ÁúÀÌ °¡¿ª¼ºÀ¸·Î ºÎÂøÇϴ ºÐÀÚ.
¿µ¹® vegetative state ÇÑ±Û ½Ä¹°»óÅÂ
¼³¸í   
  ÀÚÀ²½Å°æ°è´Â È°µ¿Çϰí ÀÖÀ¸³ª ¼öÀǿÀÌ ÀüÇô ºÒ´ÉÇÑ »óŸ¦ ¸»ÇÑ´Ù. µû¶ó¼­ È£Èí, ½É¹ÚÀº Áö¼ÓÇϰí ÀÖÀ¸³ª ÀǽÄÀûÀΠȰµ¿À» ÀÏÀ¸Å°´Â ÀÏÀº ÇÒ ¼ö ¾ø´Ù. ¿øÀÎÀº µÎºÎ¿Ü»ó-ôÃß¼Õ»ó-³úÇ÷°ü¼Õ»ó-³úô¼öÁ¾¾ç-Áßµ¶ µî ¿©·¯ °¡Áö°¡ ÀÖÁö¸¸, °¡Àå ¸¹Àº °ÍÀº ±³Åë»ç°í µî¿¡ ÀÇÇÑ ¸Ó¸®¿Ü»óÀÌ´Ù. ´ë³úÀǠǥÃþºÎ´Â ´ë³ú°ÑÁúÀ̶ó Çϴµ¥, ÀÌ °÷¿¡´Â ¹é ¼ö ½Ê¾ïÀÇ ½Å°æ¼¼Æ÷°¡ ¸ð¿© À־ ¿îµ¿-°¨°¢-ÀǽĠµîÀÇ ÀÛ¿ëÀ» ´ã´çÇϰí ÀÖ´Ù. ÀÌ ´ë³ú°ÑÁúÀÇ ¼Õ»óÀ» ÀÔÀ¸¸é ¿îµ¿±â´ÉÀ̳ª ÀǽÄÀÌ Á¤ÁöµÇ°í, ³úÁٱⰡ ´ã´çÇϴ ȣÈí±â´É-¼ÒÈ­±â´É-½ÉÀå¹Úµ¿±â´É ¹Û¿¡ ÇÏÁö ¸øÇϰԠµÈ´Ù.
¿µ¹® persistent vegetative state ÇÑ±Û Áö¼Ó½Ä¹°»óÅÂ
¼³¸í   
  ±× ºÎÀ§¿¡ »ó°ü¾øÀÌ ³ú¼Õ»ó¿¡ ÀÇÇØ¼­ ÀϾ´Â °¢¼º»óÅ¿¡ À־ÀÇ ½ÉÇÑ ¹«¹ÝÀÀ»óÅ·μ­, ´ë³ú°ÑÁúÀÇ ±â´ÉÁ¤Áö, ¿ÜºÎȯ°æ¿¡ ´ëÇÑ ÀûÀýÇÑ ÀûÀÀ¹ÝÀÀÀÇ °á¿©, ¹«µ¿, ¹«¾ðÀ» Æ¯Â¡À¸·Î Çϸç, ³úÆÄ´Â Æòźȭ ¶Ç´Â ÀÌ»óȰµ¿À» ³ªÅ¸³½´Ù.
¿µ¹® hepatitis ÇÑ±Û °£¿°
¼³¸í   
  °£¿¡ »ý±â´Â ¿°ÁõÀ» ÅëÆ²¾î À̸£´Â ¸». ¹ß¿­-Ȳ´Þ-Àü½Å±ÇÅÂ-¼ÒÈ­ Àå¾ÖÀÇ Áõ»óÀ» º¸À̴µ¥, ÁֵȠ¿øÀÎÀº À½½Ä¹°°ú Ç÷¾×À» ÅëÇÑ ¹ÙÀÌ·¯½º °¨¿°À̸砱נ¹Û¿¡ ¾à¹°, ¾ËÄÚ¿Ã, ¾Ë·¹¸£±â µîÀÌ ¿øÀÎÀΠ°Íµµ ÀÖ´Ù. ÀÌ °£¿°Àº ±× Áö¼Ó±â°£¿¡ µû¶ó¼­ ±Þ¼º°£¿°°ú ¸¸¼º°£¿°À¸·Î ³ª´©´Âµ¥, ¸¸¼º°£¿°Àº 6°³¿ù À̻󠰣¿°ÀÌ Áö¼ÓµÇ´Â °æ¿ì¸¦ ¸»ÇÏ°í ±Þ¼º°£¿°Àº 6°³¿ù ÀÌ»ó Áö¼ÓÇÏÁö ¸øÇϴ °æ¿ì¸¦ ¸»ÇÑ´Ù. ±Þ¼º°£¿°Àº ¸·¿¬ÇÑ ¸íĪÀ¸·Î¼­, °£ÀÇ ±Þ¼º-½ÇÁú¼º »óÇØÀÇ °ÅÀÇ ÀüºÎ¸¦ Æ÷°ýÇϴ ³ÐÀº °³³äÀÌÁö¸¸, ½ÇÁ¦´Â ¹ÙÀÌ·¯½ºÀÇ °¨¿°À¸·Î »ý±â´Â °£¿°ÀÌ ´ëºÎºÐÀÌ´Ù. ¹ÙÀÌ·¯½º¼º °£¿°Àº À¯Ç༱°£¿°(AÇü)°ú Ç÷û°£¿°(BÇü)ÀÇ µÎ Á¾·ù°¡ Àִµ¥, À̵éÀº ¸ðµÎ Àü¿°¼º ÁúȯÀÌÁö¸¸ °¨¿° °æ·Î´Â ´Ù¸£´Ù. °¨¿° °æ·Î·Î À¯Ç༱°£¿°¹ÙÀÌ·¯½º´Â Ç÷¾×-»ùâÀÚ¾×-´ëº¯ Áß¿¡¼­ Áõ¸íµÇ¹Ç·Î Àü¿°µÈ ¹°-À½½ÄÀ» ÅëÇÏ¿© °æ±¸°¨¿°µÇ°Å³ª È¯ÀÚ¿ÍÀÇ Á÷Á¢ Á¢ÃË¿¡ ÀÇÇØ¼­ °¨¿°µÈ´Ù. Ç÷û°£¿°Àº ¿À·ÎÁö ºñ°æ±¸Àû °¨¿°À¸·Î È¯ÀÚÀÇ Ç÷û, Ç÷¾×ÀÇ ÁÖ»ç, È¯ÀÚÀÇ Ç÷¾×¿¡ °¨¿°µÈ ÁÖ»ç±â µîÀ¸·Î °¨¿°µÈ´Ù. Àẹ±â´Â À¯Ç༺°£¿°ÀÌ 2~6ÁÖ°£À̰í, Ç÷û °£¿°Àº 6ÁÖ~6°³¿ù °¡·® µÈ´Ù. Ç÷û°£¿°Àº À¯ÇàÀÇ °èÀý-¿¬·É°ú´Â °ü°è°¡ ¾øÀ¸³ª, À¯Ç༺°£¿°Àº ÁַΠ°¡À»¿¡¼­ °Ü¿ï¿¡ °ÉÃÄ ¸¹°í Ã»¼Ò³â¿¡ ¸¹´Ù. Áõ¼¼´Â ¹ßº´Çϱâ 1ÁÖÀÏ ÀüºÎÅÍ ¿Â¸öÀÌ ³ë°ïÇÏ°í ½Ä¿åÀÌ ¶³¾îÁö¸ç µÎÅëÀÌ ÀÖ°í »óº¹ºÎ¿¡ ºÒÄè°¨ÀÌ »ý±â´Âµ¥, À¯Ç༺°£¿°¿¡¼­´Â È²´ÞÀÌ ³ªÅ¸³ª±â Àü¿¡ ¹ß¿­(38¡É ÀüÈÄ)ÀÌ ÀÖÀ» ¶§°¡ ¸¹°í ¼öÀÏ ÈÄ¿¡ ÇØ¿­µÈ´Ù. ¶Ç, °üÀý-Ç㸮°¡ ¾ÆÇà¶§µµ ÀÖ¾î Ã³À½¿¡´Â °¨±â·Î ¿ÀÀÎÇÒ ¶§°¡ ¸¹´Ù. Ç÷û°£¿°Àº ÀÌ·¯ÇÑ Ãʱâ Áõ¼¼°¡ °¡º±°í ¼­¼­È÷ ¹ßº´Çϴ °ÍÀÌ ¸¹´Ù. ÁÖÁõ¼¼´Â À§ÀåÁõ¼¼¿Í È²´ÞÀ̸ç, ½Ä¿åºÎÁø-±¸Åä-±¸¿ªÁú, »óº¹ºÎÀÇ µÐÅë µîÀÌ ÀϾ¸ç, ¹ßº´ ÈÄ 4~5ÀÏ¿¡ È²´ÞÀÌ ³ªÅ¸³­´Ù. È²´ÞÀº 1ÁÖÀÏÀ» ÀüÈÄÇÏ¿© ÃÖ°í¿¡ À̸£¸ç, ±× ÈÄ 1°³¿ù »çÀÌ¿¡ ¾ø¾îÁö¸é¼­ ´Ù¸¥ Áõ¼¼µµ ÁÁ¾ÆÁø´Ù. °æ°ú´Â ±Þ¼º°£¿°Àº ¾à 70%°¡ ´ë°³ 1~3°³¿ù À̳»¿¡ Ä¡À¯µÇÁö¸¸ »¡¸® Ä¡·áµÇÁö ¾Ê´Â °Í Áß 15%°¡ ¸¸¼º°£¿°À¸·Î ÀÌÇàÇϸç, ±× ÀϺδ °£°æÈ­ÁõÀ¸·Î ÀÌÇàÇÑ´Ù. ±Þ¼º°£¿° Áß¿¡´Â ¶§·Î´Â 10ÀÏ À̳»¿¡ »ç¸ÁÇϴ Àü°Ý¼º°£¿°À̶ó°í Çϴ °Íµµ ÀÖ´Ù. º´ÀÇ Àüü °æ°ú ÁߠȲ´ÞÀÌ ³ªÅ¸³ªÁö ¾Ê´Â ¹«È²´Þ¼º °£¿°À̶ó°í Çϴ °Íµµ ÀÖ¾î. ¸¸¼º°£¿°À¸·Î ÀÌÇàÇϴ °Í¿¡´Â ÀÌ ¹«È²´Þ¼ºÀÌ ¸¹Àº °æÇâÀÌ ÀÖ´Ù. Ç÷û°£¿°µµ ¸¸¼ºÈ­Çϱ⠽±´Ù.
¿µ¹® acute hepatitis ÇÑ±Û ±Þ¼º°£¿°
¼³¸í   
  ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ °£¿¡ »ý±â´Â ±Þ¼º¿°Áõ. ±Þ¼º°£¿°À̶õ °£¿°¹ÙÀÌ·¯½º(AÇü-BÇü-ºñAºñBÇü)¿¡ ÀÇÇØ¼­ °£¿¡ »ý±â´Â ±Þ¼º¿°ÁõÀ» º´¸íÀ¸·Î À̸£´Â ¸»·Î, À̴ ±× °¨¿°¾ç½Ä¿¡ ¼öÇ÷ ÈÄ¿¡ ¹ß»ýÇϴ ¼öÇ÷ÈÄ °£¿°°ú, °¨¿°°æ·Î¸¦ ¾Ë ¼ö ¾ø´Â »ê¹ß¼º°£¿° ¹× Áý´ÜÀ¸·Î ¹ß»ýÇϴ À¯Ç༱°£¿°ÀÇ ¼¼°¡Áö À¯ÇüÀ¸·Î ³ª´­ ¼ö ÀÖ´Ù. ¼öÇ÷ÈÄ °£¿°Àº ±× 95%°¡ ºñAºñBÇü°£¿°À̸砳ª¸ÓÁö°¡ BÇü °£¿°ÀÌ´Ù. »ê¹ß¼º °£¿°Àº AÇü °£¿°°ú BÇü °£¿°ÀÌ °¢°¢ 30%¸¦ ÀÌ·ç°í ³ª¸ÓÁö 40%´Â ºñAºñB°£¿°ÀÌ´Ù. Áý´ÜÀ¸·Î ¹ß»ýÇϴ À¯Ç༺°£¿°Àº °ÅÀǰ¡ AÇü°£¿°ÀÌÁö¸¸ ¶§·Î´Â ¿©±â¿¡ Æ÷ÇÔµÇÁö ¾ÊÀº ÇüÀÇ °£¿°ÀÏ °æ¿ìµµ ÀÖ´Ù. ±Þ¼º°£¿°ÀÇ Áõ¼¼´Â ¸ÕÀú ¸öÀÌ ³ª¸¥ÇØÁö°í ¿Â¸ö¿¡ ±ÇۨÀ̠ã¾Æ¿À¸ç Á¶±×¸¶ÇÑ ÀÏ¿¡µµ °ð ÇǷθ¦ ´À³¢°Ô µÈ´Ù. ±×¸®°í ½Ä¿åºÎÁø-¹ß¿­-±¸ÅäÁõ-º¹Åë-¼³»ç µî, °¨±â³ª ±Þ¼ºÀ§Àå¿°¿¡ °É·ÈÀ» ¶§¿Í °°Àº Áõ¼¼ µîÀÌ ³ªÅ¸³­´Ù. µÚÀ̾î È²´ÞÁõ¼¼¸¦ º¸À̴µ¥, À̶§´Â ÃʱâÀÇ Áõ¼¼°¡ ¾à°£ °¡º­¿öÁø °Íó·³ ´À²¸Áö´Â °ÍÀÌ º¸ÅëÀÌ´Ù. ±×·¯³ª È²´ÞÁõ¼¼°¡ ½ÉÇØÁö°í ÃʱâÀÇ Áõ¼¼µéÀÌ ´Ù½Ã ÁøÇàµÇ¸é À̶§´Â Àü°Ý¼º°£¿°ÀÌ µÉ À§ÇèÀÌ ÀÖ´Ù. °£¿° Áõ¼¼°¡ ½ÉÇÏÁö ¾Ê¾ÒÀ» °æ¿ì´Â È²´ÞÀÌ ´«¿¡ ¶çÁö ¾ÊÀº °æ¿ìµµ Àִµ¥ À̶§´Â ÁøÂûÀ» Çصµ °¨±â³ª ±Þ¼ºÀ§Ã¢ÀÚ¿°À¸·Î ÀÚÄ© ¿ÀÁøµÇ±â ½±´Ù. ¶Ç AÇü°£¿°Àº ¿­ÀÌ 38~39¡É±îÁö ¿À¸£°í Áõ¼¼°¡ °©Àڱ⠳ªÅ¸³ª´Â °ÍÀ̠Ư¡À̸砱޼ººñAºñBÇü°£¿°Àº Áõ¼¼°¡ ºñ±³Àû °¡º­¿î °ÍÀ̠Ư¡ÀÌ´Ù. ±Þ¼ºBÇü°£¿°ÀÇ Áõ¼¼´Â AÇü°£¿°°ú ±Þ¼ººñAºñBÇü°£¿°ÀÇ Áß°£ Á¤µµÀΠ°ÍÀÌ º¸ÅëÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carrier state
    º¸±Õ»óÅÂ
  • asymptomatic carrier
    ¹«Áõ»óº¸±ÕÀÚ
  • amalgam carrier
    ¾Æ¸»°¨³ª¸£°³, ¾Æ¸»°¨¿î¹Ýü
  • constant carrier
    °è¼Óº¸±ÕÀÚ
  • convalescent carrier
    ȸº¹±âº¸±ÕÀÚ
  • cyst carrier
    ³¶º¸ÃæÀÚ
  • carrier
    1. º¸±ÕÀÚ, º¸ÃæÀÚ 2. º¸ÀÎÀÚ 3. ³ª¸£°³, ¿î¹Ýü
  • carrier determinant
    ¿î¹Ýü°áÁ¤ÀÎÀÚ
  • carrier effect
    ¿î¹Ýüȿ°ú
  • carrier mediated transport
    ¿î¹Ýü¸Å°³¿î¹Ý
  • carrier protein
    ¿î¹Ý´Ü¹éÁú
  • electron carrier
    ÀüÀÚ¿î¹Ýü
  • healthy carrier
    °Ç°­º¸±ÕÀÚ
  • hemophiliac carrier
    Ç÷¿ìº´º¸ÀÎÀÚ
  • heterozygous carrier
    ÀÌÁ¾Á¢ÇÕº¸ÀÎÀÚ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carrier
    º¸±ÕÀÚ, º¸ÃæÀÚ, º¸ÀÎÀÚ, ³ª¸£°³, ¿î¹Ýü
  • heterozygous carrier
    ÀÌÁ¾Á¢ÇÕº¸ÀÎÀÚ
  • hepatitis
    °£¿°
  • acute hepatitis
    ±Þ¼º°£¿°
  • neonatal hepatitis
    ½Å»ý¾Æ°£¿°
  • serum hepatitis
    Ç÷û°£¿°
  • viral hepatitis
    ¹ÙÀÌ·¯½º°£¿°
  • state
    »óÅÂ
  • basal state
    ±âÃÊ»óÅÂ
  • ordinary state
    Á¤»ó»óÅÂ
  • panic state
    °øÈ²»óÅÂ
  • persistent vegetative state
    Áö¼Ó½Ä¹°»óÅÂ
  • postprandial state
    ½ÄÈÄ»óÅÂ
  • refractory state
    ¹«¹ÝÀÀ»óÅÂ
  • relaxation state
    À̿ϻóÅÂ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hepatitis carrier state
    °£¿°º¸±ÕÀÚ»óÅÂ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carrier state
    º¸±Õ»óÅÂ
  • amalgam carrier
    ¾Æ¸»°¨³ª¸£°³, ¾Æ¸»°¨¿î¹Ýü
  • asymptomatic carrier
    ¹«Áõ»óº¸±ÕÀÚ
  • carrier
    º¸±ÕÀÚ, º¸ÃæÀÚ, º¸ÀÎÀÚ, ³ª¸£°³
  • carrier determinant
    ¿î¹Ýü°áÁ¤±â
  • carrier effect
    ¿î¹Ýüȿ°ú
  • carrier protein
    ¿î¹Ý´Ü¹é, ¿î¹Ý´Ü¹éÁú
  • carrier specificity
    ³ª¸£°³Æ¯À̼º, ¸Å°³Æ¯À̼º, ¿î¹ÝüƯÀ̼º
  • carrier mediated transport
    ¿î¹Ýü¸Å°³¿î¹Ý
  • constant carrier
    °è¼Óº¸±ÕÀÚ
  • convalescent carrier
    ȸº¹±âº¸±ÕÀÚ
  • cyst carrier
    ³¶º¸ÃæÀÚ
  • electron carrier
    ÀüÀÚ¿î¹Ýü
  • healthy carrier
    °Ç°­º¸±ÕÀÚ
  • hemophiliac carrier
    Ç÷¿ìº´º¸ÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hepatitis,carrier state
    º¸±ÕÀÚ(ÜÁжíº)
  • amalgam carrier
    ¾Æ¸»°¨¼ö¼Û±â(¡­âÃáêÐï).
  • healthy carrier
    °Ç°­º¸±ÕÀÚ(ÊÙËÓË»Ëö). ±â»ý°Ç°­º¸ÃæÀÚ(ÊÙËÓ̧Ëö).
  • hemophiliac carrier
    Ç÷¿ìº´ÀÎÀÚº¸À¯ÀÚ.
  • hemophiliac carrier
    Ç÷¿ìº´ÀÎÀÚº¸À¯ÀÚ.
  • heterozygous carrier
    ÀÌÁ¾Á¢ÇÕº¸À¯ÀÚ.
  • hod carrier s palsy
    Àâ¿ë ¿î¹ÝÀÚ ¸¶ºñ(íÚéÄê¡Úæíº Ýö).
  • hod carrier s palsy
    Àâ¿ë¿î¹ÝÀÚ¸¶ºñ(íÚéÄê¡Úæíº Ýö).
  • DESS (double echo in the steady state)
    Ç×Á¤ »óÅÂÀÇ ÀÌÁß ¿¡ÄÚ
  • FAST(Fourier acquisition in the steady state) sequen
    Ç×Á¤ »óÅ¿¡¼­ÀÇ Fourier ȹµæ ¿¬¼â
  • Mini-Mental State Examination(MMSE)
    °£ÀÌÁ¤½Å»óŰ˻ç(ÊÛì¯ïñãêßÒ÷¾ËþÞÛ)
  • Present State Examination
    Çö»óŰ˻磨úÞßÈ÷¾ËþÞÛ£©
  • SSFP ( steady state free precession)
    Ç×Á¤ »óÅ ÀÚÀ¯ ¼¼Â÷
  • accessory state
    µ¡»óÅÂ
  • acute confusional state
    ±Þ¼º È¥µ· »óÅÂ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hepatitis,carrier state
    º¸±ÕÀÚ(ÜÁжíº)
  • dream state, dream-like state, dreamy state
    ¸ù·Õ»óÅÂ(ÙÔÖèßÒ÷¾).
  • carrier state
    º¸±Õ»óÅÂ
  • amalgam carrier
    ¾Æ¸»°¨¼ö¼Û±â(¡­âÃáêÐï).
  • asymptomatic carrier
    ¹«Áõ»óº¸±ÕÀÚ.
  • bacillus carrier
    ¼¼±Õº¸±ÕÀÚ(á¬Ð¶ÜÁжíº).
  • bacteria carrier
    ¼¼±Õº¸±ÕÀÚ.
  • carrier
    ¹Ý¼ÛÆÄ, ij¸®¾î
  • carrier
    º¸±ÕÀÚ, ¿î¹Ýü, ´ãü
  • carrier
    ¿î¹Ýü(ê¡Úæô÷)
  • carrier determinant
    ¿î¹Ýü °áÁ¤±â
  • carrier effect
    ¿î¹Ýü È¿°ú
  • carrier mediated diffusion
    ´ãü(¸Å°³) È®»ê.
  • carrier mediated transport
    ¿î¹Ýü¸Å°³ À̵¿
  • carrier prophylactic
    ij¸®¾î¿¹¹æÁ¦.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Crypt state
    ¿ò»óÅÂ
    [¿¾ ¿ë¾î] Àº¿Í»óÅÂ
  • Proliferative state
    Áõ½Ä»óÅÂ
    [¿¾ ¿ë¾î] Áõ½Ä±â
  • Vestigial state
    ÈçÀû»óÅÂ
    [¿¾ ¿ë¾î] ÈçÀû»óÅÂ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amebic hepatitis
    ¾Æ¸Þ¹Ù°£¿°
  • carrier
    º¸ÃæÀÚ
  • convalescent carrier
    ȸº¹±âº¸ÃæÀÚ
  • healthy carrier
    °Ç°­º¸ÃæÀÚ
  • permanent carrier
    ¿µ±¸º¸ÃæÀÚ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hepatitis B surface antigen
    BÇü(úþ) °£¿°(ÊÜæú) Ç¥¸é Ç׿ø(øúØüù÷ê«)
  • type A hepatitis
    AÇü(úþ) °£¿°(ÊÜæú)
  • type B hepatitis
    BÇü(úþ) °£¿°(ÊÜæú)
  • viral hepatitis
    ¹ÙÀÌ·¯½º¼º °£¿° (ÊÜæú)
  • acyl-carrier protein
    ¾Æ½Ç¿î¹Ý ´Ü¹éÁú (ê¡ÚæÓ±ÛÜòõ)
  • ATP-ADP carrier
    ATP-ADP ¿î¹Ýü(ê¡Úõô÷)
  • biotin carboxyl carrier protein
    ¹ÙÀÌ¿Àƾ Ä«¸£º¹½Ç ¿î¹Ý´Ü¹éÁú(ê¡ÚæÓ±ÛÜòõ)
  • carboxyl carrier protein
    Ä«¸£º¹½Ç ¿î¹Ý´Ü¹éÁú(ê¡ÚæÓ±ÛÜòõ)
  • carrier
    "ij¸®¾î, ¿î¹Ýü(ê¡Úæô÷)"
  • carrier ampholyte
    ij¸®¾î ¾ç¼ºÀüÇØÁú(Õ×àõï³ú°òõ)
  • carrier displacement chromatography
    ij¸®¾î ġȯ(öÇüµ) Å©·Î¸¶Åä±×·¡ÇÇ
  • carrier-facilitated diffusion
    ij¸®¾î ÃËÁø È®»ê(õµòäüªß¤)
  • carrier gas
    ¿î¹Ýü(ê¡Úæô÷)°¡½º
  • carrier protein
    ¿î¹Ýü´Ü¹éÁú(ê¡Úæô÷Ó±ÛÜòõ)
  • C55 lipid carrier
    "C55 ÁöÁú¿î¹Ýü(ò·òõê¡Úæô÷),(ÔÒ) bactoprenol"
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carrier
    ¹Ý¼ÛÆÄ, ij¸®¾î, º¸À¯ÀÚ, º¸±ÕÀÚ, ´ãü
  • healthy carrier
    °Ç°­º¸±ÕÀÚ, °Ç°­º¸ÃæÀÚ
  • fulminant hepatitis
    Àü°Ý¼º°£¿°
  • hepatitis
    °£¿°
  • hepatitis B virus
    BÇü °£¿°¹ÙÀÌ·¯½º
  • infectious hepatitis virus
    Àü¿°¼º°£¿°¹ÙÀÌ·¯½º
  • CE FAST [=contrast enhanced fast acquisition in the steady state]
    Ç×Á¤»óÅÂÀÇ ´ëÁ¶µµÁõ°­°í¼Óȹµæ
  • DESS [=double echo in the steady state]
    Ç×Á¤»óÅÂÀÇ ÀÌÁß¿¡ÄÚ
  • excitation state
    ¿©±â»óÅÂ, ÈïºÐ»óÅÂ
  • fast imaging with steady state precession [=FISP]
    Ç×Á¤»óż¼Â÷¿îµ¿À» ÀÌ¿ëÇÑ °í¼Ó¿µ»ó
  • FAST(Fourier acquisition in the steady state) sequence
    Ç×Á¤»óÅ¿¡¼­ÀÇ Fourierȹµæ¿¬¼â
  • Fourier acquisition in the steady state [=FAST]
    Ç×Á¤»óÅ¿¡¼­ÀÇ Fourierȹµæ
  • partial saturation state
    ºÎºÐÆ÷È­»óÅÂ
  • relaxation state
    À̿ϻóÅÂ
  • saturation state
    Æ÷È­»óÅÂ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AH abdominal hysterectomy; absorptive hypercalciuria; accidental hypothermia; acetohexamide; acid hydro...
LES Lambert-Eaton syndrome; Lawrence Experimental Station [agar]; local excitatory state; Locke egg seru...
SH Salter-Harris [fracture]; Schonlein-Henoch [purpura]; self-help; serum hepatitis; sexual harassment;...
CAH chronic active hepatitis; chronic aggressive hepatitis; combined atrial hypertrophy; congenital adre...
HA H antigen; Hakim-Adams [syndrome]; halothane anesthesia; Hartley [guinea pig]; headache; health alli...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AAC ADP-ATP carrier
ACP Acyl Carrier Protein
ACP Acyl-acyl carrier protein
acyl-ACP Acyl-acyl carrier protein
ACP Beta-Ketoacyl-acyl carrier protein
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute hepatitis
    ±Þ¼º °£¿°
    ÀÌ º´¸íÀº ¸·¿¬ÇÑ ¸íĪÀ¸·Î¼­, °£ÀÇ ±Þ¼º¡¤½ÇÁú¼º »óÇØÀÇ °ÅÀÇ ÀüºÎ¸¦ Æ÷°ýÇÏ´Â ³ÐÀº °³³äÀÌÁö¸¸, ½ÇÁ¦´Â ¹ÙÀÌ·¯½ºÀÇ °¨¿°À¸·Î »ý±â´Â °£¿°ÀÌ ´ëºÎºÐÀ̰í, °£µ¶¡¤È­Çоàǰ¡¤ÀǾàǰ µîÀ¸·Î »ý±â´Â Áßµ¶¼º °£¿°µµ ºñ±³Àû ¸¹´Ù. ¹ÙÀÌ·¯½º¼º °£¿°Àº À¯Ç༺ °£¿°
  • amalgam carrier
    ¾Æ¸»°¨ ¼ö¼Û±â
    ¹°··¹°··ÇÑ ¾Æ¸»°¨À» »èÁ¦ÇÑ ¿Íµ¿À̳ª Ʋ ¼ÓÀ¸·Î ¿î¹ÝÇϴµ¥ »ç¿ëÇÏ´Â µµ±¸.
  • bacteria carrier
    ¼¼±Õ º¸±ÕÀÚ
  • carrier
    º¸±ÕÀÚ, ij¸®¾î, º¸À¯ÀÚ, ´ãü, º¸Çè¾÷ÀÚ
    1. ÁúȯÀÇ ÀÓ»ó ¼Ò°ßÀº ¾øÀÌ Æ¯º°ÇÑ °¨¿° ÀÎÀÚ¸¦ °¡Áö°í ´Ù¸¥ »ç¶÷À» °¨¿°½Ãų ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ´Â »ç¶÷. °Ç°­Çϰųª ȸº¹±â¿¡ ÀÖ´Â º¸±ÕÀÚÀÏ ¼ö ÀÖ´Ù. 2. Á¦±âµÈ ÀÌÀǸ¦ ÇØ°áÇØ Áְųª Ä¡·á¸¦ Á¦°øÇϱâ·Î µ¿ÀÇÇÑ Ä¡°ú Ä¡·á °è¾àÀÚ Ãø.
  • carrier mediated transport
    ¿î¹Ýü ¸Å°³ À̵¿
  • carrier specificity
    ¿î¹Ýü ƯÀ̼º
  • cholestatic hepatitis
    ´ãÁó ¿ïü¼º °£¿°, ´ãÁó Á¤Ã¼¼º °£¿°
  • chronic active hepatitis
    ¸¸¼º Ȱµ¿¼º °£¿°
  • chronic carrier
    ¸¸¼º º¸±ÕÀÚ
  • chronic hepatitis B
    ¸¸¼º BÇü °£¿°
  • electron carrier
    ÀüÀÚ ¿î¹Ýü
  • epidemic hepatitis
    À¯Ç༺ °£¿°
  • foil carrier
    ±Ý¹Ú ¼ö¼Û±â
    foil
  • healthy carrier
    °Ç°­ º¸±ÕÀÚ, °Ç°­ º¸ÃæÀÚ
    Áõ»óÀÌ ¾øÀ¸¸é¼­ ±ÕÀ» °¡Áö°í ÀÖ´Â »ç¶÷.
  • hepatitis
    °£¿°
    °£ÀÇ ¿°Áõ¼º Áúȯ. °£Àå¿°À̶ó°íµµ ÇÑ´Ù. °£ ÁúȯÀÇ ´ëºÎºÐÀ» Â÷ÁöÇÏ´Â °ÍÀ¸·Î¼­, Å©°Ô ±Þ¼º °£¿°°ú ¸¸¼º °£¿°À¸·Î ³ª´«´Ù. ¡¼±Þ¼º °£¿°¡½ ÀÌ º´¸íÀº ¸·¿¬ÇÑ ¸íĪÀ¸·Î¼­, °£ÀÇ ±Þ¼º, ½ÇÁú¼º »óÇØÀÇ °ÅÀÇ ÀüºÎ¸¦ Æ÷°ýÇÏ´Â ³ÐÀº °³³äÀÌÁö¸¸, ½ÇÁ¦´Â ¹ÙÀÌ·¯½ºÀÇ °¨¿°À¸·Î »ý±â´Â °£¿°ÀÌ ´ëºÎºÐÀ̰í, °£µ¶, È­ÇÐ ¾àǰ, ÀǾàǰ µîÀ¸·Î »ý±â´Â Áßµ¶¼º °£¿°µµ ºñ±³Àû ¸¹´Ù. ¹ÙÀÌ·¯½º¼º °£¿°Àº À¯Ç༺ °£¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
carrier state A condition in which a human who is not himself sick harbors an infective organism which may cause disease in those to whom it is transmitted.
(12 Dec 1998)
acetoacetyl-acyl carrier protein synthase <enzyme> E coli enzyme, that catalyses condensation of malonyl-acyl carrier protein plus acetyl-acyl carrier protein; not inhibited by cerulenin
Registry number: EC 2.3.1.-
Synonym: acetoacetyl-acp synthase
(26 Jun 1999)
acyl-(acyl-carrier-protein)-phospholipid acyltransferase <enzyme> Catalyses the formation of phosphatidylethanolamine from acyl-acyl carrier protein and 2-acyl-sn-glycero-3-phosphoethanolamine
Registry number: EC 2.3.1.40
Synonym: 2-acyl-gpe acyltransferase, 2-acylglycerophosphoethanolamine acyltransferase
(26 Jun 1999)
acyl-(acyl-carrier-protein)-UDP-N-acetylglucosamine acyltransferase <enzyme> E coli enzyme involved in lipid a biosynthesis; uses beta-hydroxymyristoyl-acyl carrier protein to form udp-3-monoacyl-n-acetylglucosamine; amino acid sequence given in second source
Registry number: EC 2.3.1.129
Synonym: udp-aguatransferase, lpxa protein, udp-n-acetylglucosamine-3-acyltransferase, udp-n-acetylglucosamine 3-o-acyltransferase, udp-3-o-(r-3-hydroxymyristoyl)glucosamine-n-acyltransferase, lpxd protein, fira gene product, fira protein
(26 Jun 1999)
acyl carrier protein <protein> A small (77 peptides long) protein which binds six other enzymes involved in fatty acid synthesis. It was first isolated in E. Coli bacteria.
(09 Oct 1997)
acyl carrier protein acylase <enzyme> From E coli
Registry number: EC 2.3.1.-
Synonym: acp acylase
(26 Jun 1999)
amalgam carrier An instrument used to transport triturated amalgam to a cavity preparation and to deposit it therein.
(05 Mar 2000)
beta-hydroxyacyl-(acyl-carrier-protein)dehydrase <enzyme> In fatty acid synthesis; specific for acyl carrier protein; cannot use acyl CoA; see also faba gene product
Registry number: EC 4.2.1.-
Synonym: beta-ohacyl-acp dehydrase, beta-hydroxyacyl-acyl carrier protein dehydratase, fabz gene product
(26 Jun 1999)
galactose-diphosphoglycosyl carrier lipid synthetase <enzyme> Catalyses synthesis of gcl-pp-gal from udp gal and p-gcl; also catalyses exchange between the uridylyl moiety of udpgal and ump
Registry number: EC 2.4.1.-
(26 Jun 1999)
malonyl-CoA-acetyl CoA-acyl carrier protein S-acyltransferase <enzyme> Specific for either malonyl-CoA or acetyl-CoA; a component of fatty acid synthase
Registry number: EC 2.8.3.-
Synonym: mcoa-acoa acp acyltransferase
(26 Jun 1999)
manifesting carrier An organism heterozygous for what is ordinarily a recessive condition which, as a result of special mechanisms (such as lyonization, allelic exclusion, or a deletion in the homologous chromosome), has phenotypic manifestations.
Synonym: manifesting carrier.
(05 Mar 2000)
genetic carrier An unaffected heterozygote bearing a usually harmful recessive gene, a cancer that bears a dominant but latent age-dependent trait to have offspring with unbalanced karyotypes.
(05 Mar 2000)
carrier 1. <genetics, microbiology> An individual who does not display the symptoms of a disease, but harbors the pathogen which causes it, or has the gene (or genes) for it, and can transmit the disease to others either through interacting with other individuals, or by passing the disease-causing gene (or genes) to offspring.
2. <pharmacology> A substance which transports things, such as a carrier protein.
(09 Oct 1997)
carrier cell <cell biology> A cell that is capable of phagocytosis. The main mammalian phagocytes are neutrophils and macrophages.
Origin: L. Phagedaena, Gr Phago, To eat.
(18 Nov 1997)
carrier electrophoresis Electrophoresis done on a carrier (such as paper, polyacrylamide gel, etc.).
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hepatitis
    °£¿°
  • hepatitis A
    AÇü °£¿°;Àü¿°¼º(Ç÷û)°£¿°
  • carrier
    º¸±ÕÀÚ
  • air carrier
    Ç×°øÈ¸»ç;Ç×°ø±â
  • atomic carrier
    ¿øÀÚ·Â Ç×°ø ¸ðÇÔ
  • atonic carrier
    ¿øÀÚ·Â Ç×°ø¸ðÇÔ
  • car carrier
    (¼öÃâ¿ë)ÀÚµ¿Â÷ ¿î¹Ý¼±
  • carrier
    ¿î¹ÝÀÎ;¿ìÆíÁý¹è¿ø;½Å¹® ¹è´Þ¿ø;¿î¼Û¾÷ÀÚ;¿î¼Ûȸ»ç;¿î¹Ý ¼³ºñ;ÁüÆÇ(ÀÚÀü°Å µîÀÇ);Àü¿°º´ ¸Å°³Ã¼;º¸±ÕÀÚ;(À¯ÀüÀÚÀÇ)º¸ÀδÙ;Ç×°ø¸ðÇÔ;¼Ò¼Û±â;¿î¹Ý¼±;=CARRIER WAVE;¹è¼ö±¸;Çϼö·Î;´ãü;SHOPPING BAG
  • carrier bag
    =SHOPPING BAG
  • carrier nation
    ÇØ¿î±¹
  • carrier pigeon
    Àü¼­±¸
  • carrier rocket
    ¿î¹Ý¿ë ·ÎÄÏ
  • carrier wave
    ¹Ý¼ÛÆÄ
  • cash carrier
    (ÀºÇà µî Á¡³»ÀÇ)±ÝÀü ¼ö¼Û±â
  • common carrier
    ÀÏ¹Ý ¿î¼ö¾÷ÀÚ(öµµ.Ç×°øÈ¸»ç µî)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á